Vimta Labs Ltd
NSE:VIMTALABS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (3.8), the stock would be worth ₹353.01 (24% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 5 | ₹462.8 |
0%
|
| 3-Year Average | 3.8 | ₹353.01 |
-24%
|
| 5-Year Average | 3.5 | ₹329.42 |
-29%
|
| Industry Average | 4 | ₹375.93 |
-19%
|
| Country Average | 3.3 | ₹303.83 |
-34%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Vimta Labs Ltd
NSE:VIMTALABS
|
21.1B INR | 5 | 27.6 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 142.4 | 4 280.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
176.7B USD | 3.3 | 26.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
125.4B USD | 2.4 | 34 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 6.8 | 46.1 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
298.9B CNY | 3.8 | 15.6 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.3B CHF | 3.8 | -118.2 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.7B USD | 4.7 | 25.3 | |
| US |
|
Waters Corp
NYSE:WAT
|
30.4B USD | 11.9 | 47.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.5B USD | 4.3 | 20.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.1B USD | -1 104.7 | 30 |
Market Distribution
| Min | 0 |
| 30th Percentile | 2.1 |
| Median | 3.3 |
| 70th Percentile | 5.5 |
| Max | 4 699.1 |
Other Multiples
Vimta Labs Ltd
Glance View
Vimta Labs Ltd. engages in the provision of contract research and testing. The company is headquartered in Hyderabad, Telangana and currently employs 1,273 full-time employees. The Company’s business includes analytical, clinical, preclinical services to life sciences industries; quality and safety testing for food and beverage industries; and environment services to a wide spectrum of industries. The firm provides services of testing and contract research in the fields of analytical food and water, preclinical research, clinical research, biopharma, environmental assessments and clinical reference lab. The company supports regulatory authorities in mandatory certification of food and agricultural products exported from India. The company assists the food industry for nutritional labelling, food safety evaluations, trace analysis and shelf life studies. Its environmental services include site selection and liability studies; environmental impact assessments; environment management plans and carrying capacity-based regional studies.
